Publication | Closed Access

Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy

ChromatinImatinib TherapyOncologyOctn2 Transporters GenesGastrointestinal OncologyMedicineProlonged TimePathologyColorectal CancerCancer GenomicsCancer GeneticsMolecular DiagnosticsRadiation OncologyCancer Research